Detalhe da pesquisa
1.
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19.
Int J Mol Sci
; 24(7)2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37047594
2.
Nursing-sensitive outcomes in adult inflammatory bowel disease: A systematic review.
J Adv Nurs
; 77(5): 2248-2266, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33426709
3.
The awareness of the IBD nurse position among patients from an Italian tertiary IBD centre.
Prof Inferm
; 73(3): 213-218, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355782
4.
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients.
Indian J Gastroenterol
; 43(1): 215-225, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244138
5.
Fecal transplantation for ulcerative colitis from diet conditioned donors followed by dietary intervention results in favorable gut microbial profile compared to fecal transplantation alone.
J Crohns Colitis
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720628
6.
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission.
J Gastrointestin Liver Dis
; 32(4): 452-459, 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147610
7.
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center.
Inflamm Bowel Dis
; 29(11): 1805-1818, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37280117
8.
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Inflamm Bowel Dis
; 29(3): 376-383, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579320
9.
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial.
J Crohns Colitis
; 16(3): 369-378, 2022 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514495
10.
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy.
J Gastrointestin Liver Dis
; 31(4): 411-416, 2022 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535057
11.
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy.
Expert Opin Biol Ther
; 22(2): 313-320, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904510
12.
The gut-brain axis in irritable bowel syndrome and inflammatory bowel disease.
Dig Liver Dis
; 53(3): 298-305, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33303315
13.
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy.
Expert Opin Biol Ther
; 21(11): 1483-1489, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34521307
14.
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre.
United European Gastroenterol J
; 8(7): 775-781, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438878
15.
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center.
Nutrients
; 11(10)2019 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554166